'The United States doesn’t have a market-based economy for prescription drugs. 'It has a shame-based economy.' Davidlaz writes:
Cigna and Express Scripts say consumers with drug benefits managed by the company could see their out-of-pocket costs for insulin limited to $25 a month. Healthcare experts say that's not good enough. It has a shame-based economy.
Just wondering, though: Considering that insulin has been around for about a century, and that costs have skyrocketed for no good reason except that the worldwide market is controlled by just three pharmaceutical companies, why has it taken until now to suddenly worry about the welfare of people with diabetes?The public and, more importantly, lawmakers have grown increasingly fed up with indefensibly high drug costs, and there’s a feeling among some policymakers that price controls should be on...
That means, he told me, that the only way drug prices will be reduced is through a price war with a competitor , or by attracting the attention of lawmakers and regulators through “public outrage and corporate shaming.” But James Robinson, director of UC Berkeley’s Center for Health Technology, told me that what’s more likely here is that the companies are merely shifting their revenue sources.
He said it’s a near-certainty that as copays and coinsurance are reduced for people with diabetes, which is basically what Cigna and Express Scripts are doing, the losses for insurers will be offset by higher premiums for everyone. When drug maker Eli Lilly introduced its Humalog insulin in 1996, it cost $21 a vial, which is about a month’s supply. Everyone involved made a handsome profit.off the chronically ill.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cigna, Express Scripts launch program to cap insulin costs at $25 for 30-day supplyCigna Corp. and Express Scripts announced Wednesday its Patient Assurance Program, which caps costs for a 30-day supply of insulin at $25 for eligible people...
Read more »
New insulin price won't top $25 a month out-of-pocket, Cigna saysHealth insurer Cigna is launching a program that will cap out-of-pocket expenses at $25 for a 30-day supply of insulin
Read more »
“We Knew This Was Coming”: Parkland Is Once Again In Crisis Mode After Two SuicidesMore than a year after the Marjory Stoneman Douglas High School shooting, two young people have killed themselves. The community is now working overtime to offer support.
Read more »
An investor once told Lyft's founders he was 'not sure about this carpool thing'An investor once told Lyft's founders he was 'not sure about this carpool thing' via CNBCMakeIt
Read more »
How betting on oil prices greases the industry’s wheelsThe message from futures markets is that high spot prices will not last
Read more »
Biogen SMA drug price, Novartis estimates for its treatment far too high - U.S. groupBiogen Inc should slash the price of its spinal muscular atrophy (SMA) drug, and...
Read more »
FDA’s Gottlieb heads back to AEI to tackle drug pricesScott Gottlieb, the FDA commissioner who will step down Friday, plans to return to the American Enterprise Institute to write about and research drug prices.
Read more »